GENEVA, Oct. 6 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (6701 Rockledge DriveSuite 700, MSC 7788Bethesda, Maryland 20892-7788) filed a patent application (PCT/US2025/021789) for "RADIOLABELED GLYPICAN-3 (GPC3)-SPECIFIC SINGLE DOMAIN ANTIBODY AND USE THEREOF AS AN IMAGING AGENT FOR DETECTION OF GPC3-POSITIVE TUMORS" on Mar 27, 2025. With publication no. WO/2025/207909, the details related to the patent application was published on Oct 02, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ESCORCIA, Freddy E. (10 Center Drive, B2-36...